 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Edarbi® | TAK 491
                                 azilsartan medoxomil is an approved drug (EMA & FDA (2011)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Azilsartan medoxomil is metabolised into the active form azilsartan. The azilsartan ligand page (accessed via the link above) contains more details of the drug's clinical use and mechanistic action.  The marketed brand, Edarbi®, contains azilsartan medoxomil potassium (PubChem CID 23699544).   View more information in the IUPHAR Pharmacology Education Project: azilsartan medoxomil | 
 | |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| As a prodrug this compound is unlikely to have significant activity. Therefore we have not tagged a primary target for this compound. |